课题基金 / 基金详情

Gene therapy for hepatocellular carcinoma

Gene therapy for hepatocellular carcinoma
肝细胞癌的基因治疗
批准号:
11670516
负责人:
IDO Akio
金额:
$0.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

IDO Akio的其他基金

相似基金

相关文献

中文摘要
翻译
我们先前报道,在0.3kb的人甲胎蛋白(α)基因启动子(AF0.3)控制下,表达单纯疱疹病毒胸苷激酶(HSV-tk)基因的逆转录病毒载体对更昔洛韦(GCV)在高甲胎蛋白产生的人肝癌细胞中具有细胞毒作用,而在低甲胎蛋白产生的细胞中不具有细胞毒作用。因此,可能需要特异性地增强AFP启动子的活性,以在低AFP产生的肝癌细胞中诱导足够的细胞毒性。在本研究中,我们构建了一个含有缺氧反应元件(HRE)的人血管内皮生长因子(VEGF)5‘端0.4kb片段与AF0.3启动子融合的杂合启动子[HRE]AF。通过报告基因转染实验,在低AFP和不产生AFP的人肝癌细胞中检测到由[HRE]AF启动子介导的低氧诱导转录,而在非肝癌细胞中检测不到。用逆转录病毒载体将[HRE]AF启动子控制的HSV-tk基因导入肝癌和非肝癌细胞,1%O2可诱导肝癌细胞产生GCV-细胞毒作用。此外,在荷实体瘤移植瘤的裸鼠中,只有由感染病毒的肝癌细胞组成的肿瘤通过给予GCV逐渐消失。这些结果表明,低氧诱导的人血管内皮生长因子基因增强子与人AFP启动子直接相连,参与了肝癌基因治疗中选择性和增强的杀瘤活性。
英文摘要
We previously reported that the retroviral vector expressing the herpes simplex virus-thymidine kinase (HSV-tk) gene under the control of 0.3-kb human α-fetoprotein (AFP) gene promoter (AF0.3) provided the cytotoxicity to ganciclovir (GCV) in high-AFP-producing human hepatoma cells but not in low-AFP-producing cells. Therefore, specific enhancement of AFP promoter activity is likely to be required to induce enough cytotoxicity in low-AFP-producing hepatoma cells. In this study, we constructed a hybrid promoter, [HRE]AF, in which a 0.4-kb fragment of human vascular endothelial growth factor (VEGF) 5'-flanking sequences containing hypoxia responsive element (HRE) was fused to AF0.3 promoter. By means of the reporter gene transfection assay, hypoxia-inducible transcriptions that were mediated by [HRE]AF promoter were detected in low- and non-AFP-producing human hepatoma cells, but not in nonhepatoma cells. When the HSV-tk gene controlled by [HRE]AF promoter was transduced into hepatoma and nonhepatoma cells by a retroviral vector, the exposure to 1% O2 induced GCV-cytotoxicity specifically in the hepatoma cells. Moreover, in nude mice bearing solid tumor xenografts, only the tumors consisting of the virus-infected hepatoma cells gradually disappeared by GCV administration. These results indicate that the hypoxia-inducible enhancer of the human VEGF gene, which is directly linked to human AFP promoter, involves selective and enhanced tumoricidal activity in gene therapy for hepatocellular carcinoma.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Akio Ido et al.: "Gene therapy targeting for hepatocellular carcinoma : selective and enhanced suicide gene expression regulated by hypoxia-inducible enhancer linked to human a-fetoprotein promoter."Cancer Research. 61(in press). (2001)
Akio Ido 等人:“针对肝细胞癌的基因治疗:通过与人甲胎蛋白启动子连接的缺氧诱导增强子调节选择性和增强的自杀基因表达。”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirofumi Uto et al..: "Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene."Biochem.Biophys.Res.Commun.. 265. 550-555 (1999)
Hirofumi Uto 等人:“使用携带亲嗜性受体基因的腺病毒,通过逆转录病毒介导的靶向基因转移进行肝癌特异性基因治疗。”Biochem.Biophys.Res.Commun.. 265. 550-555 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ido A, Uto H, et al.: "Gene therapy targeting for hepatocellular carcinoma : Selective and enhanced gene expression regulated by hypoxia-inducible enhancer linked to human α-fetoprotein promoter"Cancer Research. 61 (in press). (2001)
Ido A、Uto H 等人:“针对肝细胞癌的基因治疗:通过与人 α-胎蛋白启动子连接的缺氧诱导增强子调节选择性和增强的基因表达”癌症研究 61(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
坪内博仁 他2名: "肝細胞癌の遺伝子治療-将来の展望"臨床消化器内科. 14・7. 268-278 (1999)
Hirohito Tsubouchi 等 2 人:“肝细胞癌的基因治疗 - 未来前景”临床胃肠病学 14・7(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Involvement of osteoactivin in inflammatory hepatocarcinogenesis: analysis of mice lacking osteoacitivin expression
  • 批准号:
    22590742
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2010
  • 负责人:
    IDO Akio
  • 依托单位:
Involvement of osteoactivin in hepatic injury and repair
  • 批准号:
    19590763
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    IDO Akio
  • 依托单位:
Involvement of ATBF1 in liver regeneration and hepatocarcinogenesis
  • 批准号:
    17590636
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    2005
  • 负责人:
    IDO Akio
  • 依托单位:
Functional analysis of osteoactivin and its role in hepatocarcinogenesis
  • 批准号:
    14570484
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2002
  • 负责人:
    IDO Akio
  • 依托单位:
国内基金
海外基金
沉默HBX基因表达治疗肝癌的研究
  • 批准号:
    30371402
  • 项目类别:
    面上项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2003
  • 负责人:
    贺兴鄂
  • 依托单位: